CN104524538A

CN104524538A - Medicine composition for recovery phase of cancers

Info

Publication number: CN104524538A
Application number: CN201510033766.4A
Authority: CN
Inventors: 陈明
Original assignee: Individual
Current assignee: Individual
Priority date: 2015-01-22
Filing date: 2015-01-22
Publication date: 2015-04-22

Abstract

The invention relates to a medicine composition for treating a cancer patient in the recovery phase. The medicine composition is mainly prepared from the following raw materials in parts by weight: 5-40 parts of cinnabar root poria, 5-30 parts of fructus amomi, 5-40 parts of alpinia oxyphylla, 5-40 parts of rhizoma atractylodis, 5-30 parts of agastache rugosus, 5-30 parts of radix aucklandiae, 15-60 parts of prepared monkshood-tuber, 5-25 parts of honey-fried licorice root, 15-45 parts of dried ginger and 5-30 parts of cinnamomumcassia presl. Against the characteristics of whole organism reduction, hypoimmunity and the like of the cancer patient in the recovery phase, the screened traditional Chinese medicinal herbs capable of tonifying qi-blood, reinforcing vital essence, strengthening primordial qi and reinforcing body immunity are effective for improving diet and sleeping of the cancer patients in the recovery phase; furthermore, various medicinal raw materials are combined together to furthest exert the drug effect, improve the patient immunity and prolong the survival time, has the advantages of small toxic and side effect and low cost, and can be accepted by broad cancer patients.

Description

A kind of for the convalescent pharmaceutical composition of cancer

Technical field

The present invention relates to a kind of pharmaceutical composition for cancer patient convalescent care, particularly relating to a kind of take Chinese herbal medicine as the pharmaceutical composition for cancer patient convalescent care of raw material.

Background technology

According to Ministry of Public Health recent statistics, China suffers from cancer number and rises year by year, twentieth century seventies, and annual cancer morbidity is 7,000,000 people, and death toll reaches 5,000,000, to twentieth century nineties, dies from the number of cancer every year up to more than 10,000,000.Annual trouble cancer number is more with the number dying from cancer now, causes great attention that is domestic and international medical community already.

Up to the present, go up a variety of cancer therapy drugs gone on the market both at home and abroad, to human body, especially have serious side effect to the body constitution of cancer patient, be not beneficial to the eventual rehabilitation of cancer patient.

Summary of the invention

Technical problem to be solved by this invention overcomes above-described defect, and provide a kind of evident in efficacy, cost is lower, the pharmaceutical composition for cancer patient convalescent care that side effect is little.

To achieve these goals, the invention provides following technical scheme:

A kind of pharmaceutical composition for cancer patient convalescent care, mainly comprise crude drug: Poria cum Radix Pini Zhu 5 ~ 40 parts of following weight portion, Fructus Amomi 5 ~ 30 parts, Fructus Alpiniae Oxyphyllae 5 ~ 40 parts, Rhizoma Atractylodis 5 ~ 40 parts, Herba Pogostemonis 5 ~ 30 parts, the Radix Aucklandiae 5 ~ 30 parts, river processed Radix Aconiti Lateralis Preparata 15 ~ 60 parts, Radix Glycyrrhizae Preparata 5 ~ 25 parts, Rhizoma Zingiberis 15 ~ 45 parts, RAMULUS CINNAMOMI 5 ~ 30 parts.

Be preferably, the described pharmaceutical composition for cancer patient convalescent care, mainly comprises crude drug: Poria cum Radix Pini Zhu 25 parts of following weight portion, Fructus Amomi 15 parts, Fructus Alpiniae Oxyphyllae 30 parts, Rhizoma Atractylodis 15 parts, Herba Pogostemonis 15 parts, the Radix Aucklandiae 15 parts, river processed Radix Aconiti Lateralis Preparata 45 parts, Radix Glycyrrhizae Preparata 15 parts, Rhizoma Zingiberis 30 parts, RAMULUS CINNAMOMI 25 parts.

Described for the convalescent pharmaceutical composition of cancer, also comprise the crude drug of following weight portion: Semen Ziziphi Spinosae 5 ~ 45 parts, Fructus Citri Sarcodactylis 5 ~ 30 parts, Fructus Amomi Rotundus 5 ~ 45 parts, Semen Trigonellae 5 ~ 45 parts, the Radix Astragali 5 ~ 35 parts, Pericarpium Citri Reticulatae 5 ~ 35 parts.

Be preferably, described for the convalescent pharmaceutical composition of cancer, also comprise the crude drug of following weight portion: Semen Ziziphi Spinosae 30 parts, Fructus Citri Sarcodactylis 15 parts, Fructus Amomi Rotundus 15 parts, Semen Trigonellae 45 parts, the Radix Astragali 30 parts, Pericarpium Citri Reticulatae 15 parts.

Aforementioned pharmaceutical compositions of the present invention adds various customary adjuvant required when preparing different dosage form, such as disintegrating agent, lubricant, adhesive, being prepared into the conventional oral formulations of any one with the method for Chinese medicinal of routine, such as, can be pill, capsule or granule.

The present invention's herbal raw material used all can be buied from Chinese medicine shop, and its specification meets national medical standards.

Usage and dosage: dosage of the present invention depends on concrete dosage form, at the age of patient, body weight, the factors such as health status are for oral administration as guidance.Conventional dose is as follows: (1) capsule: take three every day, each serving 4 ~ 8, and every content of dispersion 0.5g, warm water takes; (2) pill: take three every day, each 10g, warm water takes; (3) granule: take three every day, each bag, often wrap 10g, warm water takes.

Beneficial effect of the present invention is:

(1) principle that combines based on Chinese medicine convalescent period cancer patient differential diagnosis of diseases Coryza Treated by Syndrome Differentiation of pharmaceutical composition of the present invention, all that diet is not good based on cancer patient's great majority, malnutrition, sleep poor, lassitude, namely the present invention is directed to the feature such as allomeric function decline, hypoimmunity of convalescent period cancer patient, filter out can benefiting vital QI and blood, element culturing fixed folder, enhancing human body immunity power Chinese herbal medicine, to convalescent period cancer patient diet sleep improvement very effective.

(2) pharmaceutical composition of the present invention can according to the concrete condition energy treating both the principal and secondary aspects of a disease of sufferer, tonifying vital QI, strengthening spleen, tonifying kidney, the diet changing patient very is soon slept bad state, improve the immunity of patient, according to requiring selected natural Chinese medicinal herb above, according to theory of Chinese medical science prescription, be prepared from according to constant weight proportioning.

(3) in the present invention, various crude drug is coordinated together mutually, farthest can play drug effect, improves the immunity of patient, extend growth time, in addition pharmaceutical composition of the present invention, toxic and side effects is little, expense is low, can be accepted by numerous Huan Ai colony.

Detailed description of the invention

Further describe the present invention by the following examples.It should be understood that these embodiments only for the object of illustration, be never limited to scope of the present invention.

The preparation of embodiment 1 capsule

Raw material: Poria cum Radix Pini Zhu 25 parts is taken, Fructus Amomi 15 parts, Fructus Alpiniae Oxyphyllae 30 parts by following weight, Rhizoma Atractylodis 15 parts, Herba Pogostemonis 15 parts, the Radix Aucklandiae 15 parts, river processed Radix Aconiti Lateralis Preparata 45 parts, Radix Glycyrrhizae Preparata 15 parts, Rhizoma Zingiberis 30 parts, RAMULUS CINNAMOMI 25 parts, is ground into fine powder by after each component mixing of above-mentioned weight, after crossing 1500 mesh sieves, incapsulate and get final product.

The preparation of embodiment 2 granule

Each raw material: Poria cum Radix Pini Zhu 25 parts is taken, Fructus Amomi 15 parts, Fructus Alpiniae Oxyphyllae 30 parts by following weight, Rhizoma Atractylodis 15 parts, Herba Pogostemonis 15 parts, the Radix Aucklandiae 15 parts, river processed Radix Aconiti Lateralis Preparata 45 parts, Radix Glycyrrhizae Preparata 15 parts, Rhizoma Zingiberis 30 parts, RAMULUS CINNAMOMI 25 parts, Semen Ziziphi Spinosae 30 parts, Fructus Citri Sarcodactylis 15 parts, Fructus Amomi Rotundus 15 parts, Semen Trigonellae 45 parts, the Radix Astragali 30 parts, Pericarpium Citri Reticulatae 15 parts.

By each crude drug mixing of above-mentioned weight, be ground into fine powder, after crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and make filler, be pressed into granule.

The preparation of embodiment 3 pill

By each for above-mentioned weight crude drug mixing, be ground into fine powder, after crossing 80 ~ 200 mesh sieves, make pill and get final product.

The clinical observation on the therapeutic effect test of embodiment 4 medicine composite for curing of the present invention convalescent period cancer patient.

(1) subjects

Pharmaceutical composition of the present invention is adopted to treat 158 example convalescent period cancer patients altogether, wherein man 84 example, female 74 example, the oldest person 80 years old, reckling 38 years old.

(2) Therapeutic Method

Usage and consumption: adopt the medicament prepared by the embodiment of the present invention, its usage and consumption as follows:

(1) capsule: take three every day, each serving 4 ~ 8, every content of dispersion 0.5g, warm water takes.

(2) pill: take three every day, each 10g, warm water takes.

(3) granule: take three every day, each bag, often wrap 10g, warm water takes.

The course for the treatment of: one month be a course for the treatment of, treat 3 courses for the treatment of altogether.

(3) efficacy assessment standard

Effective: sign has clear improvement, show as: diet increases, sleep improvement, spirit takes a turn for the better, and complexion is clearly better, and better, body weight increases the healing of patients after surgery operative scar, and night sweat symptom takes a turn for the better, and malaise symptom is improved.

Effective: sign makes moderate progress, malaise symptom is improved, and diet sleep makes moderate progress, and body weight increases to some extent, and night sweat symptom takes a turn for the better.

Invalid: sign is improved not obvious, diet sleep is constant, and body weight is constant, and malaise symptom is without improvement.

(4) diagnostic result

In treated 158 routine patients, after treating three courses for the treatment of, wherein, effective account for 60 examples, effectively account for 94 examples, invalid account for 4 examples, total effective rate reaches: 97.5%.From the above results can find out Chinese medicine of the present invention combination to convalescent period cancer patient treatment there is significant curative effect.

Model case

Case 1: in certain Ping Xu town, Panji District, man 52 years old Huainan City

The postoperative JIUYUE of patient system pulmonary carcinoma, 4 courses for the treatment of of chemotherapy, pathology is right lung scale cancer, Post operation incisxal edge has no cancerous cell, has no the transfer of lymphatic metastasis and other organs, pale complexion during patient assessment, listless, be sitting on chair, just doze off less than half an hour, diet is not fragrant, nighttime sleep is poor, and Sleep hyperhidrosis symptom is given prominence to, and eats three kinds of Western medicine every day, there is compound vitamin, also have SHENGBAI PIAN etc.

Patient advises and withdraws other drug after taking medicine of the present invention, and behind more than 20 skies, patient's diet increases, and body weight increases, and sleep takes a turn for the better, and spirit takes a turn for the better, and patient's private prosecution physical recovery is more satisfactory, and after 3 courses for the treatment of, the working of patient's receipt position, is filled with unbounded confidence to life and work.

Case 2: Bai Ying community, Tianjiaan District, Xiao female 42 years old Huainan City

In October after patient system operation for cervical carcinoma, 6 courses for the treatment of of chemotherapy, pathology is cervical gland scale cancer, operation is: total hysterectomy, without peripheral lymph node transfer, shifts without other organs, patient mental still can, pale complexion, anemia looks, diet is poor, become thin, nighttime sleep is general, and dream is many, night sweat symptom is heavier, the medicine such as oral " SHENGBAI PIAN " and " leucogen ".

After patient takes a course for the treatment of of medicine of the present invention, conscious health is easily strong, and weak symptom is obviously improved, and complexion slightly turns ruddy, and diet increases, and nighttime sleep is more heavy, reduces before dream comparatively, and night sweat symptom takes a turn for the better, and withdraws gradually " SHENGBAI PIAN " and " leucogen ".

Case 3: Cao Zui village, Shun Geng town, Tianjiaan District of Wang man 49 years old Huainan City

Patient system postoperative gastric cancer 10 months, 4 courses for the treatment of after chemotherapy, pathology is middle differentiation adenocarcinoma.Modus operandi: total gastrectomy, without lymphatic metastasis at a distance, without liver and other Organ relative weight, during patient assessment, dim complexion, becomes thin obviously, spirit is poor, every day, breakfast, lunch and dinner were all based on liquid, and diet is not fragrant, became thin obviously, nighttime sleep is poor, malaise is obvious, and operative incision healing is good, but has dull pain (having streak hard object under operative incision) during otch.

After patient takes medicine more than 20 sky of the present invention, sensation diet increases gradually, sleep improvement, and spirit takes a turn for the better, confidence increases, after continuing three courses for the treatment of of oral medicine of the present invention, weight in patients is significantly increased (80 jin → 100 jin), has rosy cheeks, health is light, the streak hard object deliquescing of operative incision, dull pain sense disappears, and sleeps peacefully every day more than 8 hours.

Case 4: Li Yingzi town, Xiejiaji District, man 52 years old Huainan City, river

After patient system carcinoma of prostate chemotherapy in postoperative October 4 times, pathology is adenocarcinoma of prostate, and modus operandi is: per urethra carcinoma of prostate electrotomy, without Bone tumour and other Organ relative weight, during patient assessment, pale complexion, becomes thin, diet sleep is all poor, and sexual function extreme difference, perspires more at ordinary times.Patient takes medicine of the present invention, a course for the treatment of, and diet sleep is all clearly better, and has rosy cheeks, and perspires and obviously reduces.

(note: the present invention's Radix Aconiti Lateralis Preparata used all needs to fry to be concocted).

Claims

1. the pharmaceutical composition for cancer patient convalescent care, it is characterized in that: crude drug: Poria cum Radix Pini Zhu 5 ~ 40 parts mainly comprising following weight portion, Fructus Amomi 5 ~ 30 parts, Fructus Alpiniae Oxyphyllae 5 ~ 40 parts, Rhizoma Atractylodis 5 ~ 40 parts, Herba Pogostemonis 5 ~ 30 parts, the Radix Aucklandiae 5 ~ 30 parts, river processed Radix Aconiti Lateralis Preparata 15 ~ 60 parts, Radix Glycyrrhizae Preparata 5 ~ 25 parts, Rhizoma Zingiberis 15 ~ 45 parts, RAMULUS CINNAMOMI 5 ~ 30 parts.

2. the pharmaceutical composition for cancer patient convalescent care according to claim 1, it is characterized in that: crude drug: Poria cum Radix Pini Zhu 25 parts mainly comprising following weight portion, Fructus Amomi 15 parts, Fructus Alpiniae Oxyphyllae 30 parts, Rhizoma Atractylodis 15 parts, Herba Pogostemonis 15 parts, the Radix Aucklandiae 15 parts, river processed Radix Aconiti Lateralis Preparata 45 parts, Radix Glycyrrhizae Preparata 15 parts, Rhizoma Zingiberis 30 parts, RAMULUS CINNAMOMI 25 parts.

3. the pharmaceutical composition for cancer patient convalescent care according to claim 1, is characterized in that: the crude drug also comprising following weight portion: Semen Ziziphi Spinosae 5 ~ 45 parts, Fructus Citri Sarcodactylis 5 ~ 30 parts, Fructus Amomi Rotundus 5 ~ 45 parts, Semen Trigonellae 5 ~ 45 parts, the Radix Astragali 5 ~ 35 parts, Pericarpium Citri Reticulatae 5 ~ 35 parts.

4. the pharmaceutical composition for cancer patient convalescent care according to claim 1, is characterized in that: the crude drug also comprising following weight portion: Semen Ziziphi Spinosae 30 parts, Fructus Citri Sarcodactylis 15 parts, Fructus Amomi Rotundus 15 parts, Semen Trigonellae 45 parts, the Radix Astragali 30 parts, Pericarpium Citri Reticulatae 15 parts.

5. be used for the pharmaceutical composition of cancer patient convalescent care according to any one described in Claims 1 to 4, it is characterized in that: method of Chinese medicinal routinely can be prepared into the conventional oral formulations of any one.

6. the pharmaceutical composition for cancer patient convalescent care according to claim 5, is characterized in that, described peroral dosage form is the one in capsule, pill or granule.